Sumanta K Pal Selected Research

Sumanta K Pal Research Topics

Disease

120	Renal Cell Carcinoma (Grawitz Tumor) 12/2022 - 08/2011
88	Neoplasms (Cancer) 12/2022 - 09/2011
35	Prostatic Neoplasms (Prostate Cancer) 09/2021 - 09/2011
26	Carcinoma (Carcinomatosis) 12/2022 - 04/2015
22	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022 - 12/2012
19	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2012
11	Disease Progression 01/2022 - 04/2016
11	Kidney Neoplasms (Kidney Cancer) 01/2021 - 05/2012
5	Fatigue 01/2020 - 07/2017
5	Breast Neoplasms (Breast Cancer) 12/2012 - 01/2010
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2015
4	Circulating Neoplastic Cells 01/2021 - 05/2015
3	Urogenital Neoplasms 01/2021 - 01/2017
3	Diarrhea 07/2017 - 05/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2020
2	Hyperphosphatemia 12/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2020 - 05/2012
2	Liver Neoplasms (Liver Cancer) 12/2019 - 05/2015
2	Hand-Foot Syndrome 10/2019 - 04/2018
2	Mucositis 10/2019 - 04/2018
2	Anemia 07/2017 - 04/2015
1	Medullary Carcinoma 12/2022

Drug/Important Bio-Agent (IBA)

20	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2017
19	Biomarkers (Surrogate Marker)IBA 07/2022 - 07/2013
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2014
17	Sunitinib (Sutent)FDA Link 01/2021 - 02/2014
12	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2014
11	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 12/2012
10	NivolumabIBA 01/2022 - 10/2017
10	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2015
9	cabozantinibIBA 01/2022 - 01/2019
9	Everolimus FDA Link 01/2022 - 11/2014
8	IpilimumabIBA 01/2022 - 01/2015
8	PlatinumIBA 12/2021 - 01/2017
7	Sorafenib (BAY 43-9006)FDA Link 10/2021 - 05/2012
7	Pharmaceutical PreparationsIBA 01/2021 - 07/2013
7	Circulating Tumor DNAIBA 01/2021 - 05/2017
7	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2012
7	Biological ProductsIBA 01/2021 - 01/2013
7	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 07/2013
7	AndrogensIBA 04/2019 - 09/2011
6	atezolizumabIBA 11/2021 - 10/2017
6	Docetaxel (Taxotere)FDA Link 09/2021 - 11/2012
6	Axitinib (AG 013736)IBA 11/2020 - 05/2012
6	TOR Serine-Threonine KinasesIBA 06/2016 - 10/2014
5	infigratinibIBA 07/2022 - 01/2018
5	tivozanibIBA 10/2021 - 12/2012
5	enzalutamideIBA 01/2021 - 04/2013
5	LigandsIBA 01/2021 - 01/2018
5	pazopanib FDA Link 12/2018 - 01/2017
4	Gemcitabine FDA Link 10/2021 - 05/2013
4	Formaldehyde (Formol)FDA Link 11/2020 - 05/2015
4	ParaffinIBA 11/2020 - 05/2015
4	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2016
4	RNA (Ribonucleic Acid)IBA 02/2019 - 07/2013
4	MTOR InhibitorsIBA 06/2016 - 11/2013
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2019
3	B7-H1 AntigenIBA 01/2022 - 01/2020
3	pembrolizumabIBA 08/2020 - 10/2017
3	PPAR gammaIBA 01/2020 - 05/2018
3	CytokinesIBA 04/2019 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	Toll-Like Receptor 9IBA 12/2018 - 12/2013
3	taxaneIBA 06/2015 - 01/2010
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 12/2014
2	CateninsIBA 02/2021 - 01/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 10/2020
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2013
2	abirateroneIBA 01/2021 - 04/2019
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2020 - 01/2018
2	avelumabIBA 11/2020 - 10/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 04/2015
2	Warfarin (Coumadin)FDA LinkGeneric 02/2017 - 01/2017
2	temsirolimus FDA Link 04/2016 - 11/2014
2	cabazitaxel FDA Link 12/2015 - 12/2012
2	Prostate-Specific Antigen (Semenogelase)IBA 09/2015 - 01/2015
2	Vinblastine (Vinblastine Sulfate)FDA Link 08/2015 - 12/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015 - 12/2012
2	Methotrexate (Mexate)FDA LinkGeneric 08/2015 - 12/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015 - 01/2014
2	Hormones (Hormone)IBA 05/2015 - 04/2010
1	Fumarate Hydratase (Fumarase)IBA 12/2022
1	lenvatinibIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022

Therapy/Procedure

121	Therapeutics 12/2022 - 04/2010
27	Immunotherapy 01/2022 - 09/2011
20	Castration 09/2021 - 09/2011
18	Drug Therapy (Chemotherapy) 12/2021 - 04/2010
11	Nephrectomy 01/2022 - 06/2014
9	Cystectomy 12/2020 - 05/2013
5	Neoadjuvant Therapy 10/2020 - 05/2013
4	Adjuvant Chemotherapy 07/2022 - 03/2016
3	Precision Medicine 01/2021 - 01/2020
3	Radiotherapy 01/2019 - 12/2013
2	Drug Tapering 10/2021 - 04/2018
2	Prostatectomy (Retropubic Prostatectomy) 12/2018 - 01/2017
2	Chemoradiotherapy 04/2018 - 10/2016
2	Metastasectomy 01/2018 - 01/2017
2	Ligation 03/2016 - 01/2016